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Cardiovascular diseases increase continually in the worldwide scale, and 
its specific pathogenesis has not been completely clear. The gas signal 
molecule hydrogen sulfide (H2S) is a new type of neuroactive substance, 
which plays many biological roles in many systems such as cardiovascular 
system. In recent years, a lot of research has confirmed H2S has myocardial 
protective effect on cardiovascular diseases such as atherosclerosis, isch-
emia-reperfusion injury, hypertension and heart failure. This paper reviews 
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1. The Research Background
With the continuous progress of social develop-ment level and the aging process of population structure in China, the continuous increase 
of cardiovascular patients received in clinic, which has 
seriously affected people’s health[1].In the past decade, 
scholars at home and abroad have done a lot of researches 
on the prevention and treatment of cardiovascular disease, 
but still have not found an effective cure[2].In 2014 Xu et 
al [3] studies indicate that the behavior of  hydrogen sulfide 
(H2S) is similar to nitric oxide (NO) and carbon monoxide 
(CO), and may exert  myocardial protective effects by 
inhibiting mitochondrial pathways ,resisting Ca2+overload 
and antioxidant stress. This paper will summarize and 
analyze the latest research progress of H2S in myocardial 
protection and therapeutic potentialn in cardiovascular 
system diseases such as ischemia-reperfusion injury, 
atherosclerosis, hypertension and heart failure of recent 
years, the aim is to provide a new idea for the clinical pre-
vention and treatment of cardiovascular diseases such as 
ischemia-reperfusion injury.
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2. Generation and Metabolism of H2S 
The production of H2S in mammals has two pathways: 
non-enzyme catalysis and enzyme catalysis. H2S in the 
non-enzyme pathway is mainly produced by elemental 
sulfur and sulfur-containing compounds, only a small part 
of H2S is produced by the non-enzyme catalytic pathway, 
and most of H2S is produced by the enzyme catalytic path-
way. It has been found that the production of endogenous 
H2S is regulated by the following five enzymes: D-amino 
acid oxidase (DAO), cysteine-lyase (CSE), cysteine -syn-
thase (CBS)[4], cysteine transaminase (CAT), and 3-mer-
captopyruvate sulftransferase (3-MST)[5]. For example, 
DAO is mainly distributed in the kidney and cerebrum, 
CBS is mainly distributed in the central nervous system, 
CAT and 3-MST can synthesize H2S in the brain and vas-
cular endothelium, and CSE is the most critical enzyme in 
the sulfur transfer pathway of the human cardiovascular 
system[6]. L-cysteine is the main catalytic substrate for 
CSE, CBS and CAT, while D-cysteine is the substrate for 
DAO and 3-MST[7]. H2S generated in the body is mainly 
characterized in two forms:1/3 is in the form of H2S, and 
2/3 is in the form of Sodium hydrosulfide (NaHS), H2S 
and NaHS can be transformed into each other and form a 
dynamic balance in vivo[8] (H2S: NaHS=1:2).The endoge-
nous H2S is rapidly oxidized to thiosulphates and sulfates 
in the mitochondria of cells catalyzed by a variety of en-
zymes and detoxified, and finally discharged through the 
kidneys, intestines and lungs[9].
3. Effects of H2S on Cardiovascular Disease
Endogenous H2S level is mainly regulated by H2S gen-
erating enzyme. When the expression or activity of the 
generating enzyme is down-regulated, H2S level will be 
significantly reduced, leading to cardiovascular disease. 
Gao et al.[10] found in their study that compared with nor-
mal subjects, Plasma H2S level was significantly reduced 
in patients with coronary atherosclerosis.Hong Kong et 
al. conducted a study on 110 patients with coronary heart 
disease using sensitive sulfur electrode method to deter-
mine the plasma H2S content and found that the plasma 
H2S level in patients with acute myocardial infarction and 
unstable angina was lower than that in patients with stable 
angina[11].Salloum et al[12]. Found that endogenous H2S can 
not only reduce myocardial ischemia-reperfusion injury, 
but also regulate blood pressure, fight atherosclerosis, 
promote vasodilation and regulate negative myocardial 
strength. The myocardial protective effect of endogenous 
H2S on cardiovascular diseases has been confirmed, and 
the myocardial protective effect of exogenous H2S on 
cardiovascular diseases has been gradually confirmed. 
Supplementation of exogenous H2S can also reduce myo-
cardial injury, improve heart failure and improve cardiac 
function.
3.1 H2S and Ischemia-Reperfusion Injury
Myocardial ischemia is mainly refers to the blood perfu-
sion of heart is reduced caused by Atherosclerosis ( AS), 
leading to reduced oxygen supply to the heart, circulatory 
failure, or even sudden death , reperfusion is necessary to 
improve myocardial ischemia , but the injurious chang-
es caused in the ischemic period are more serious after 
recanalization, irreversible myocardial damage, serious 
arrhythmia and even lead to sudden death.Through com-
parative analysis of 100 patients with acute myocardial 
infarction and 100 patients with normal coronary angiog-
raphy, He Bosheng et al[13]. found that H2S content could 
determine the scope and clinical efficacy of myocardial in-
farction, and confirmed that H2S has a certain correlation 
with myocardial ischemia reperfusion injury. When myo-
cardial ischemia occurs, H2S mediated chemical modifica-
tion of cardiac protein is significantly increased, thereby 
rapidly activating protective pathways, increasing coro-
nary microvascular reactivity, improving cardiac function, 
and ultimately reducing the damage caused by myocardial 
ischemia to the body[15].In addition, some scholars have 
pointed out that pretreatment with H2S donor (NaHS) 
before ischemia also has a certain myocardial protection 
effect.Studies on rat myocardial ischemia model indicate 
that animals with reduced CSE activity and significantly 
reduced endogenous H2S could increase myocardial per-
fusion, improve arrhythmia, and thus reduce myocardial 
injury after artificial NaHS pretreatment[16].The following 
is a summary of several major mechanisms by which H2S 
exerts myocardial protection.
3.1.1 Mechanism 1: Anti-apoptosis
Numerous studies have shown that H2S plays a crucial 
role in its resistance to apoptosis by inhibiting mitochon-
drial pathways and endoplasmic reticulum pathways.Mi-
tochondrial pathway is the endogenous apoptosis pathway, 
in which the anti-apoptotic protein Bcl-2 gene and the 
pro-apoptotic protein Bax gene can change the mitochon-
drial membrane integrity, and their relative levels deter-
mine the fate of cells and are key factors affecting the sur-
vival of myocardial cells[6]. The expression of Bcl-2 gene 
in mitochondrial outer membrane can inhibit the transport 
of cytochrome C to cytoplasm and thus resist apoptosis.
After activation , Bax gene is inserted the mitochondrial 
outer membrane through allosteric translocation, thus 
destroying the integrity of the membrane ,and resisting 
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anti-apoptotic proteins, thus promoting cell apoptosis. H2S 
up-regulated the expression of anti-apoptotic protein Bcl-
2 and decreased the expression of pro-apoptotic protein 
Bax, finally achieving the purpose of anti-apoptosis and 
protecting cardiomyocytes[17].Citi et al. found that H2S 
inhibited apoptosis by down-regulating mRNA and pro-
tein expression levels of transcription factor homologous 
protein, an important molecule of unfolded protein, and 
glucose-regulating protein 78 during myocardial ischemia 
and reperfusion[18].
3.1.2 Mechanism 2: Antioxidant Stress
During ischemia-reperfusion, the increase of free radi-
cals,reactive oxygen species (ROS) and Reactive nitro-
gen species (RNS) in the body leads to lipid peroxidation 
of biofilms, imbalance of oxidation system and antioxi-
dant system, DNA damage, and finally myocardial cell 
damage[19]. Al-Magableh et Al have shown that H2S can 
reduce ROS and protect vascular endothelium under 
acute stress by decomposing single electron chemicals 
such as HS-[20]. Zhang et al[21]. treated the rats with hydro-
gen peroxide (H2O2), an activated oxygen donor, to sim-
ulate acute ischemia-reperfusion injury, the pretreatment 
of H2S donor before H2O2 treatment revealed that H2S 
donor could reduce oxidative stress, thereby protecting 
myocardial cells.
3.1.3 Mechanism 3: Anti-Ca2 + Overload
During ischemia-reperfusion, a large amount of Ca2+ 
aggregation can change the permeability of mitochon-
drial membrane by activating the phospholipase on the 
mitochondrial membrane, and finally cause myocardial 
damage.Numerous studies have demonstrated that H2S 
protects cardiomyocytes against Ca2+ overload, there-
by reducing the incidence of cardiovascular disease.
Studies have found that H2S can promote the opening of 
ATP-sensitive potassium channels and accelerate the up-
take of Ca2+ in the sarcoplasmic reticulum. H2S can also 
inhibit Ca2+ overload and avoid excessive contraction of 
cardiomyocytes by inhibiting the opening of L-type Ca2+ 
channels[22].In addition, H2S can enhance the activity of 
Ca2+-ATPase in the sarcoplasmic reticulum by activating 
protein kinase C(PKC) in myocardial tissue, acceler-
ate Ca2+ exchanger-mediated ion exchange, inhibit Ca2+ 
overload, and thus reduce ischemia-reperfusion induced 
cardiac infarction.After slow injection of H2S donor into 
myocardial ischemia rat models, Ca2+ overload can be in-
hibited, thus reducing myocardial ischemia range and pro-
moting cardiac function recovery, resulting in significant 
myocardial protective effects[23].
3.2 H2S and Atherosclerosis
The role of H2S in AS pathological changes cannot be ig-
nored, such As Wang treatment with NaHS apolipoprotein 
E knockout (apoE - / -) mice, the study found that H2S can 
inhibit expression of the aortic intercellular adhesion mol-
ecule - 1 ( ICAM 1) , ICAM - 1 plays an important role 
in the formation and developmentn of thrombosis and As 
, the direct relationship between H2S and AS lesions was 
demonstrated for the first time [24].A large number of studies 
have shown that H2S has various vascular protective effects 
against As diseases, including regulating blood lipid con-
tent, promoting endothelial cell proliferation and migration, 
reducing foam cell formation, inhibiting platelet aggre-
gation, and inhibiting the expression of aortic chemokine 
receptor 1 antibody (CX3CR1) and chemokine CX3CL1.
Zhao et al. demonstrated that H2S can inhibit the production 
of foam cells through the CATP/ERK1/2 pathway of human 
monocyte derived macrophages[25]；After NaHS treatment, 
intracellular lipid accumulation was reduced, indicating 
that H2S had a certain effect on inhibiting the As lesions.Du 
et al[26]. found that H2S reduces macrophage inflammation 
induced by ox-LDL by inhibiting the phosphorylation of 
nuclear factor Bp65, thereby reducing the harmful effects 
of lipoprotein in the development of atherosclerosis.
3.3 H2S and High Blood Pressure
Collagen fibers have strong toughness and low elasticity.If 
the amount of collagen in the heart's blood vessels increas-
es,Narrow blood vessels, high blood pressure,Long-term 
hypertension is often accompanied by target organ func-
tion or organic damage, which seriously affects people's 
health and quality of life.H2S, on the other hand, relaxes 
myocardium and vascular smooth muscle in a variety of 
ways, thereby lowering blood pressure.First, H2S induces 
phosphorylation of FOXO1 and FOXO3a by inhibiting 
endothelin-1 (ET-1), thereby promoting their nuclear 
translocation and binding to the target gene promoter.Fur-
thermore, ATP sensitive potassium channel (KATP) was 
activated to significantly improve endothelium-dependent 
systolic function in hypertensive rats,promote vascular 
smooth muscle relaxation and relieve hypertension[27].Pol-
hemus et al. found that some non-specific KATP blockers 
and mitochondrial MEMBRANE KATP channel blockers 
can reduce myocardial contractile force,This leads to in-
creased cardiovascular load, which leads it is to increased 
blood pressure, while activation of the KATP channel 
reduces vascular load, which leads is in turn lowers blood 
pressure[28].In addition, Song Zhiqiang et al. stimulated 
Cl-/ HCO3- channel with NaHS to reduce intracellular 
pH value and increase H+ concentration, thus activating 
DOI: https://doi.org/10.30564/jams.v3i3.2131
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KATP channel, reducing vascular tension and alleviating 
hypertension[29].Third, regulate the balance of myocardial 
collagen fibers:Always there is a dynamic balance be-
tween the generation and degradation of myocardial col-
lagen fibers to maintain the stability of collagen content.
Once the collagen content in myocardium increases and 
the collagen configuration changes, myocardial fibrosis 
occurs.Homocysteine (Hcy) level is high in hyperten-
sive patients, and high Hcy level can affect the balance 
of myocardial collagen regulation, leading to fibrosis of 
extracellular matrix of cardiomyocytes[30].Peng chao et al. 
pointed out that endogenous H2S level can be used as a 
signal molecule of essential hypertension to reduce blood 
pressure and slow down heart rate[31].
3.4 H2S and Heart Remodeling
Cardiac remodeling is characterized by ventricular dilata-
tion, myocardial fibrosis, and heart failure.In recent years, 
there has been a significant increase in patients with heart 
failure in China. The myocardial protective effect of H2S 
is a new research direction in the field of cardiovascular 
disease, providing a new idea for the treatment of heart 
failure.Liu et al[32]. confirmed that H2S can up-regulate en-
dothelial NO level, thereby reducing stress load and pre-
venting myocardial injury.Low levels of endogenous H2S 
can lead to death in patients with heart failure[33].H2S can 
inhibit of myocardial hypertrophy and fibrosis by reduc-
ing the activity of angiotensin Ⅱ and raised link 43 (Cx43) 
protein expression .Givvimani et al[34]. found that H2S can 
activate matrix metallopro-teinases-2 (MMP-2) and inhib-
it matrix metallopro-teinases-9 (MMP-9), thereby enhanc-
ing vascular endothelial growth factor (VEGF) synthesis 
and angiogenesis , reducing the level of anti-angiogenic 
factors, and reducing intracocardial fibrosis and heart re-
modeling in mice with pressure overload. In 2017, Wu et 
al[35]. found that NaHS treatment could reduce myocardial 
cell apoptosis, interstitial fibrosis and cardiac hypertrophy 
in mice, and the overall survival rate of mice was rela-
tively high, so it was speculated that exogenous H2S had a 
good therapeutic effect on ischemic heart failure.
4. Summary and Prospect
A large number of studies have shown that H2S, a gas 
signal molecule, has a myocardial protective effect on 
cardiovascular system diseases by inhibiting apoptosis, 
resisting Ca2+ overload, anti-oxidative stress and so on. 
However, due to the narrow physiological range of H2S 
and its extremely toxic effect, relevant research data are 
mainly from mouse and other animal model experiments, 
while human experiments are seldom carried out, so there 
is still a lack of strong clinical evidence.In addition, H2S 
is also affected by statins, aspirin, metformin and other 
clinical drugs, making its clinical use more difficult[36].The 
mechanism of H2S in protecting cardiomyocytes needs to 
be further explored, and how to regulate the concentration 
of exogenous H2S for the treatment and prevention of car-
diovascular diseases also needs to be further studied.
References
[1] Ma liyuan, wu ya-zhi, Chen wei-wei. Introduction of 
key points in Chinese cardiovascular disease report 
2018 [J]. Chin J hypertension,2019 (08):712-716.
[2] Chen Yihan. Opportunities and challenges in research 
on prevention and treatment of cardiovascular diseas-
es in China [J]. World Science, 2020(04):34-36.
[3] Xu S, Liu Z, Liu P. Targeting hydrogen sulfide as a 
promising therapeutic strategy for atherosclerosis. Int 
J Cardiol. 2014 (2):313-317.
[4] Changyong Li, Min Hu, Yuan Wang, Huan Lu, Jing 
Deng, Xiaohong Yan.Hydrogen sulfide precondition-
ing protects against myocardial ischemia/reperfusion 
injury in rats through inhibition of endo/sarcoplasmic 
reticulum stress[J].International Journal of Clinical 
and Experimental Pathology, 2015 (7):7740-7751.
[5] Paul BD, Snyder SH. Gasotransmitter hydrogen 
sulfide signaling in neuronal health and disease. Bio-
chem Pharmacol. 2018(149):101-109.
[6] Chen J,Alberts I,Li X.Dysregulation of the IGF-I/
PI3K/AKT/mTOR signaling pathway in au-
tism spectrum disorders [J].Int J Dev Neuros-
ci,2014(01):35-41.
[7] Damba, Turtushikh Zhang, Mengfan Buist-Homan, et 
al. Hydrogen sulfide stimulates activation of hepatic 
stellate cells through increased cellular bio-energet-
ics. Nitric Oxide, 2019: 26-33.
[8] Li N, Wang MJ, Jin S, et al. The H2S Donor NaHS 
Changes the Expression Pattern of H2S-Producing 
Enzymes after Myocardial Infarction. Oxid Med Cell 
Longev. 2016.
[9] Zhang S H, Li J, Ma L, et al. Hydrogen sulfide me-
tabolism and neuroprotective effect. Chin J Multior-
gan Disease for the Elderly, 2019 (04): 73-77.
[10] Gao L, Xu Z, Yin Z, Chen K, Wang C, Zhang H. 
Association of hydrogen sulfide with alterations of 
monocyte chemokine receptors, CCR2 and CX3CR1 
in patients with coronary artery disease. Inflamm 
Res. 2015 (8):627-635. 
[11] Yang r, kong h, et al. Changes of hydrogen sulfide 
in patients with coronary heart disease [J]. Chinese 
journal of gerontology,2019(16):3875-3877.
[12] Salloum FN. Hydrogen sulfide and cardioprotec-
DOI: https://doi.org/10.30564/jams.v3i3.2131
16
Journal of Advances in Medicine Science | Volume 03 | Issue 03 | July 2020
Distributed under creative commons license 4.0
tion--Mechanistic insights and clinical translatability. 
Pharmacol Ther. 2015(152):11-17. 
[13] He bo-sheng, cao qia-lin, lei yong-ge. Relationship 
between hydrogen sulfide and acute myocardial in-
farction efficacy and reperfusion injury [J]. Chinese 
medical innovation,2019 (14):49-52.
[14] Sodha NR, Clements RT, Feng J, et al. Hydrogen sul-
fide therapy attenuates the inflammatory response in 
a porcine model of myocardial ischemia/reperfusion 
injury. J Thorac Cardiovasc Surg. 2009 (4):977-984.
[15] Li L, Whiteman M, Guan YY, et al. Characterization 
of a novel, water-soluble hydrogen sulfide-releasing 
molecule (GYY4137): new insights into the biology 
of hydrogen sulfide. Circulation. 2008 (18):2351-
2360. 
[16] Li Hui-xian, Li Fang-jiang, SHI Jin-zheng. Changes 
of Bcl-2 and Bax expression after simvastatin pre-
treatment of rat myocardial IRI. Shanxi Pharmaceuti-
cal Journal, 2017 (21): 26-28.
[17] Minamishima S, Bougaki M, Sips PY, et al. Hydro-
gen sulfide improves survival after cardiac arrest and 
cardio pulmonary resuscitation via a nitric oxide syn-
thase 3-dependent mechanism in mice. Circulation, 
2009 (10): 888-896 
[18] Citi V,Piragine E,Testai L,et al.The role of Hydrogen 
sulfide and H2S-donors in myocardial protection 
against ischemia/reperfusion injury[J].CurrMed-
Chem, 2018 (34):4380-4401.
[19] Miller TW, Wang EA, Gould S, et al. Hydrogen 
sulfide is an endogenous potentiator of T cell activa-
tion[J]. J Biol Chem, 2012 (6): 4211-4221
[20] Al-Magableh MR, Kemp-Harper BK, Ng HH, et al. 
Hydrogen sulfide protects endothelial nitric oxide 
function under conditions of acute oxidative stress 
in vitro[J]. Naunyn Schmiedebergs Arch Pharmacol, 
2014 (1): 67-74.
[21] Zhang p, zhang h, Yang c t, et al. Novel hydrogen 
sulfide donor 8 L antagonized H9c2 myocardial cells 
by upregulation of nf-e2-related factor 2 [J]. Chinese 
journal of arteriosclusion,2015 (6): 561-566.
[22] Abd Elmoneim H,Sharabi F,Mohy El Din M,et al.Po-
tassium channels modulate the action but not the the 
synthesis of hydrogen sulfide in rat corpuscaverno-
sum[J].LifeSci,2017(189):39-43.
[23] Hong Xie,Qingrong Xu,Jia Jia,Guizhen Ao,Ying 
Sun,Lifang Hu,Nabil J. Alkayed,Chen Wang,Jian 
Cheng. Hydrogen sulfide protects against myocar-
dial ischemia and reperfusion injury by activating 
AMP-activated protein kinase to restore autophagic 
flux[J]. Biochemical and Biophysical Research Com-
munications,2015 (3).
[24] Wang Y,Zhao X,Jin H,et al. Role of hydrogen sulfide 
in the development of atherosclerotic lesions in apo-
lipoprotein E knockout mice. Arterioscler Thromb 
Vasc Biol,2009(29):173- 179.
[25] Zhao ZZ,Wang Z,Li GH,et al. Hydrogen sulfide in-
hibits macrophage-derived foam cell formation[J].
Exp Biol Med (Maywood),2011 (2) : 169-176.
[26] Du J, Huang Y, Yan H, et al. Hydrogen sulfide sup-
presses oxidized low-density lipoprotein (ox-LD-
L)-stimulated monocyte chemoattractant protein 1 
generation from macrophages via the nuclear factor 
κB (NF-κB) pathway. J Biol Chem. 2014 (14):9741-
9753. 
[27] Xiao Lin. Mechanism of Hydrogen sulfide improving 
arterial endothelial dysfunction in hypertension [D]. 
Hebei Medical University, 2016.
[28] Polhemus DJ,Li Z,Pattillo CB,et al. A novel hydro-
gen sulfide prodrug,SG1002,promotes hydrogen 
sulfide and nitric oxide bioavailability in heart failure 
patients.Cardiovasc Ther,2015(33):216-226
[29] Song zhiqiang, zhang jianpeng. Effects of hydrogen 
sulfide on vascular smooth muscle cells [J]. Biotech-
nology communications,2015 (06) :871-875
[30] Wang jie-wen, zhang ya-ping. Progress in myocar-
dial fibrosis in patients with "H" type hypertension. 
Journal of integrated traditional Chinese and western 
medicine,2015(3): 187-188
[31] Peng Chao, Lu Yan. Central cardiovascular effects of 
a new gas signaling molecule hydrogen sulfide. Chi-
nese Journal of Hypertension,2016(24):628-631
[32] Liu YH, Lu M, Xie ZZ, et al. Hydrogen sulfide pre-
vents heart failure development via inhibition of 
renin release from mast cells in isoproterenol-treated 
rats. Antioxid Redox Signal, 2014(20): 759-769.
[33] Kovačić D, Glavnik N, Marinšek M, et al. Total plas-
ma sulfide in congestive heart failure. J Card Fail. 
2012 (7):541-548. 
[34] Givvimani S, Munjal C, Gargoum R, et al. Hydro-
gen sulfide mitigates transition from compensatory 
hypertrophy to heart failure. J Appl Physiol (1985). 
2011 (4):1093-1100.
[35] Wu T,Li H,Wu B,et al.Hydrogen Sulfide Reduces Re-
cruitment of CD11b+Gr-1+ Cells in Mice With Myo-
cardial Infarction. Cell Transplant. 2017(5):753-764.
[36] J Beltows KJ. Hydrogen sulfide in pharmacology and 
medicine—an update. Pharmacol Rep, 2015 (3): 647-
658.
DOI: https://doi.org/10.30564/jams.v3i3.2131
